1
Background & INTRODUCTION
Scope
1.1
The paper is brought to HOSC for the purposes of 1) Sharing our
internal decision-making process and rationale, and 2) Discussing
this with HOSC members prior to full implementation.
1.2
This update is in relation to East Sussex Healthcare Trust’s
(the Trust’s) Day Surgery Unit (DSU) activity at the Uckfield
Community Hospital site and does not affect any other services at
Uckfield Hospital, whether operated by the Trust, or by other
providers.
1.3
The DSU activity contributes approximately 13% of Trust activity at
the site. Other services provided by the Trust at the Uckfield site
include an outpatient department, podiatry, physiotherapy and
community dental services. These services are out of scope, and
there are no proposed changes to these services as part of this
paper.
1.4
Uckfield Community Hospital also provides services run by other NHS
organisations in the area, such as Sussex Community NHS Foundation
Trust (SCFT); and Sussex Partnership NHS Foundation Trust (SPFT).
These services are also not within the scope of this paper
1.5
The Trust do not own or operate the Uckfield site. The building is
a community resource overseen by the ICB. The Trust lease space at
Uckfield for the provision of a number of services, one of which is
the DSU and the subject of this paper.
Case for Change Summary
1.6
At Uckfield DSU, the Trust can only provide local anaesthetic
surgical procedures, which limits both the number of conditions we
see and the surgical specialties we cover.
1.7
Uckfield DSU cannot safely support general anaesthetic or overnight
care and does not carry out surgical procedures on patients with a
higher risk of complications such as those with complex needs,
certain disabilities, significant frailty and/or certain concurrent
illnesses. In these cases, even day case procedures must be carried
out in an acute hospital environment where the full scope of
supporting clinical services is on site.
1.8
Activity at Uckfield had been reducing for a number of years,
partly due to the safety criteria above, partly due to advancements
in treatment meaning theatre environments were no longer required
and this activity could take place in normal procedure rooms, and
partly because some of the procedures that we previously carried
out at Uckfield are no longer commissioned by the NHS.
1.9
The Trust were also providing DSU facilities and staff to support
other NHS Trusts, such as Plastic Surgery lists for Queen Victoria
Hospital (QVH). QVH served notice on plastics activity in April
2024, further reducing DSU activity.
1.10 For all
these reasons, the case for change illustrated that DSU activity at
Uckfield had fallen to approximately 800-850 patients per annum for
the three years prior to this proposal, as figure 1 below
shows.
Figure 1: Uckfield
DSU Activity Since 2017/18

1.11 By the
time the pilot started in December 2024, this had further reduced
to approximately 650 cases per annum.
1.12 Due to
the reduction in activity, Uckfield theatre sessions were not being
well used. A snapshot audit was conducted for the development of
the case for change, looking at utilisation rates at Uckfield DSU
for 7 months between October 2023, and April 2024 showed that
typical utilisation was around 60%. See figure 2 below.
Figure 2: Uckfield
DSU Utilisation Oct 2023 – April 2024
|
Month / Year
|
Actual Utilisation
|
|
Oct 2023
|
53.00%
|
|
Nov 2023
|
65.00%
|
|
Dec 2023
|
68.00%
|
|
Jan 2024
|
60.00%
|
|
Feb 2024
|
62.00%
|
|
Mar 2024
|
65.00%
|
|
Apr 2024
|
60.00%
|
1.13 This is
against a utilisation target of at least 85%, which was unable to
be achieved at Uckfield, and meaning that we were not making the
best use of our capacity. This would have reduced further after the
snapshot audit, due to the further fall in activity, and the
noticed served on QVH Plastics activity in April 2024.
1.14 When we
compare this to theatre utilisation at the acute hospitals,
Eastbourne District General Hospital and Conquest Hospital
Hastings, utilisation is around 82% across these sites.
1.15 We also
know that of the patients accessing these services, almost 9 out of
10 patients lived closer to one of our main hospital sites, as
shown in figure 3 below.
Figure 3: Combined
Patient Location Analysis

1.16 The data
above covers an approximately six month period, and is based on the
combination of a postcode analysis conducted at the time the case
for change was developed (showing 82% of patients lived closer the
acute sites, and 3% lived in and around Uckfield), and then
confirmed over the pilot period (which showed 88% of patients
sampled lived closer to the acute sites, and 3% lived in and around
Uckfield).
1.17 The Trust
has also recently invested in £40m worth of additional state
of the art day surgical capacity at the Sussex Surgical Centre,
which would further reduce the activity at the Uckfield DSU.
1.18 A paper
endorsed by HOSC as part of the case for investment in the Sussex
Surgical Centre (SSC, but then known at the Elective Hub)
identified at that time that 29% of activity at the Uckfield DSU
would be better provided at the SSC. This would further reduce the
activity at Uckfield DSU, making activity levels
unsustainable.
Agreement of Case for Change & Pilot Project
1.19 The case
for change was agreed by ESHT Board in August 2024, followed by
conversations with the ICB who endorsed the principles of the case
for change. A 6-month pilot period was agreed with the ICB as the
next step.
1.21 The pilot
ran from December 2024 and finished in June 2025, after which we
conducted a review of the initial data over the Summer of 2025.
Showing that we did see and treat people as quickly as possible.
The results of the pilot are summarised in section 2.
2
Pilot Evaluation RESULTS
Operational Data
2.1
The evaluation of the pilot showed that the Trust was able to
increase its capacity for elective pathways, increase our ability
to pre-assess patients in a timely manner, and improve flexibility
to provide capacity as operationally required, helping to
prioritise urgent, cancer and general anaesthetic cases.
2.2
We were able to do this without negatively impacting activity in
the specialties that were moved from Uckfield, and in some cases,
we were able provide this activity in a more appropriate location
(e.g. procedure rooms).
Patient Engagement and Access
2.3
Throughout the course of the pilot, we took soundings from patients
who supported the move of services, with the strongest theme being
that the acute sites were "clean" and "well equipped".
2.4
The evaluation also enabled us to confirm our initial analysis on
travel impact, showing that:
·
88.3% of sampled patients were able to access treatment closer to
their homes.
·
The average travel distance across the sample decreased by 10.3
miles per journey.
·
Of the 11.6% that lived closer to Uckfield 3.4% of patients were
from Uckfield or the surrounding area:
o 1.7% came
from within Uckfield (<2miles)
o 1.7% came
from “around Uckfield” (<5miles).
·
Only 6.7% patients in the sample needed to travel more than an
additional 3 miles.
·
At the time of the pilot, Uckfield DSU was seeing approximately 650
cases per annum. This would equate to approximately 43 patients a
year travelling an additional 3+ miles.
2.5
During these conversations, no patient expressed a concern that
their experience had been diminished by the move, nor were there
concerns expressed about travel or access issues.
2.6
We have also triangulated this with our patient engagement team and
confirmed that there was no negative feedback from PALS and
Complaints stemming from the pilot.
Key Findings
·
Moving the staff and activity from Uckfield to the main sites did
not reduce elective capacity across the Trust, and in some pockets,
supported increasing it.
·
Completed admitted pathways have increased during the pilot period
compared with before the pilot.
·
Long waiters (65+ weeks) have reduced over the course of the pilot
period (Please note a direct comparison with before the pilot was
not possible due to the Trust taking on 2000 cases from University
Hospitals Sussex Foundation Trust (UHSx) at this time).
·
All activity of the type provided at Uckfield has been re-provided
on the main sites.
·
Activity comparisons for particular specialties are largely in line
with expectations, and have provided assurance that capacity has
not reduced, and in some cases, capacity or productivity has
improved.
·
Some activity is now provided in a more appropriate environment,
outside of a theatre setting, and on an outpatient procedure
basis.
·
Uckfield DSU staff have been deployed flexibly across DSU roles,
and including supporting General Anaesthetic cases in main theatres
and pre-operative Assessment.
·
Uckfield DSU Staff provide at least an additional 24 pre-assessment
slots per week, and more where staff are used flexibly to support
this work, allowing us to have a larger pool of patients ready for
surgery, including at short notice.
·
The evaluation re-confirms that the majority (88.3% in this
evaluation) of patients live closer to the acute sites than
Uckfield, impacts travel times more for those who live near the
acute sites, and impacts only 3.4% of patients who live in or near
Uckfield (but does not stop them attending).
Pilot
Evaluation: Operational Performance
Activity & Performance
2.7
There has been a Trustwide increase in the number of completed
admitted pathways over the period of the pilot.
Figure 4: Average admitted
completed pathways per working day

2.8
The average number of completed admitted pathways per working day
over the baseline period was 50 per day, compared with 55 per day
for the pilot period. An average improvement of 5 completed
admitted pathways per day, or a 10% increase.
2.9
This indicates total surgical capacity increased, at least partly
driven by productivity improvements.
Impact on 65+ Week Waiting List
2.10 During
the pilot period the Trust has seen a general improvement in the
number of long waiters. As show in the figure overleaf:
Figure 5: Number of
65 week waiters over the pilot period

2.11 There was
a slight increase in 65+ week waiters in April 2025 in comparisons
to March, although numbers remain small. This may be partly
explained by leave over the Easter period
2.12 A
validated 65+ week position could only be given up to April 2025 at
the time the data was pulled for evaluation, however, we will
continue to further monitor impact to waiting times over the course
of implementation.
Activity Transferred from Uckfield DSU
2.13 The
surgical specialties that were transferred from Uckfield DSU were
Maxillofacial Surgery, Urology, Ophthalmology, Vascular Surgery,
and Dermatology.
2.14 All
Uckfield DSU activity was re-provided and rebooked at the EDGH
site. No activity has been cancelled as a result.
2.15 Most
specialties have seen an increase in capacity (more lists),
activity (more patients), or productivity (more patients per
list).
2.16
Maxillofacial surgery demonstrated an increase in cases with an
average of 22 cases per week in the pilot, compared with 20 cases
per week during the baseline, a 10% increase
2.17 Urology
increased their productivity by increasing the number of cases on a
list. This meant they could deliver the same level of activity with
fewer lists, and this releases both consultant and theatre capacity
for other clinical work. Urology ran on average 23 lists per week
the baseline period to see the same level of activity as was
achieved on only 21 lists in the pilot period, equating to a 9.5%
increase in productivity.
2.18
Ophthalmology only carried out a very small number of lists at
Uckfield (1-2 per month), and a large number of lists elsewhere,
making any impact of this pilot on Ophthalmology data relatively
small. However, ophthalmology ran on average an additional 1 list
per week over the pilot compared with the pre-pilot period (an
average of 24 lists per week during the pilot, compared with 23 in
the baseline period), confirming that this pilot has not adversely
impacted capacity.
2.19 Vascular
ran 1 list per week on average during both the baseline and pilot
periods, so there has been no reduction in vascular capacity as a
result of the relocation. However, the average number of cases
completed on those lists reduced from 3 in the baseline period, to
2 in the pilot period. Vascular have told us that this is a result
of changed pathways, meaning that less complex patients are now
seen in non-theatre settings. The theatre lists are now used for
more complex patients, which would not have been possible at
Uckfield. Please note: Vascular surgery is completed under a
Service Level Agreement (SLA) with UHSx, giving the Trust less
oversight and ownership of vascular pathways.
2.20 The
Dermatology service identified that a significant proportion of
activity going through Uckfield theatre environment did not require
a theatre at all, and that they were able to move a significant
proportion into appropriate procedure rooms. A direct comparison is
therefore not possible. However, patients are able to access
procedure rooms on an outpatient basis, meaning enhanced
flexibility, and quicker treatment pathways, due to not having to
wait for theatre availability in order for treatment to be
provided. This also has the benefit of freeing up theatre capacity
and seeing patients in a more appropriate environment. We will
continue to monitor Dermatology pathways during
implementation.
Impact on Pre-operative Assessment
2.21 During
the pilot, one member of Uckfield DSU staff has provided a further
two 12-patient pre-operative assessment clinics on the ward per
week, accounting for an additional 24 patients per week.
2.22 Other
Uckfield staff have also been able to provide additional
pre-assessment clinics, on a flexible (ad-hoc) basis which has
further increased our pre-operative assessment capacity.
2.23 This
pilot has also supported with a Trust wide Pre-operative Assessment
Improvement Project which has allowed us to standardise how we
approach Pre-assessment across the Trust.
Post-Pilot Review
2.24 Following
on from the results of the evaluation, the Trust’s executive
team reviewed the paper and came to the view that this is a change
we should make permanently.
2.25 The
evaluation was reviewed by the ESHT Board on 14 October 2025; who
endorsed the findings of the evaluation and that the proposed
change was a benefit to our patients and the populations we serve.
The board agreed the executive view that that this is a change we
should make permanently.
2.26 We
discussed the outcome of the evaluation with the ICB, and the ICB
Commissioning Group reviewed our evaluation on 14 October 2025. The
evaluation findings were endorsed, and the ICB agreed that the
proposed change was a benefit to our patients and the populations
we serve.
We met with Uckfield
staff following the evaluation to discuss our findings with them,
what these mean for the direction of our thinking, and what this
means for their role/position. We also continue to communicate and
engage with our staff and plan to implement this change permanently
following finalisation of our approach in December 2025.
Next Steps and ongoing engagement
2.27 We
anticipate being in a position to finalise our plans in December
2025, and begin implementing this as a permanent change from the
new year.
2.28 Over the
course of this timeframe and beyond, we will continue to
communicate further with our stakeholders over this period, and
throughout the implementation phase, to ensure that we make the
changes in the best way for our patients and populations, as well
as to ensure that people have all the information they need to
continue to access services, including information on travel
reimbursement schemes where eligible, NEPTS, public transport, and
car parking.
2.29 Following
implementation and ongoing communications, we will bring an
implementation update back to HOSC in June 2026.